Clinical Toxicities of Histone Deacetylase Inhibitors.docVIP

Pharmaceuticals 2010, 3, 2751-2767; doi:10.3390/ph3092751 OPEN ACCESS pharmaceuticals ISSN 1424-8247 /journal/pharmaceuticals Review Clinical Toxicities of Histone Deacetylase Inhibitors Srividya Subramanian 1, Susan E. Bates 2, John J. Wright 3, Igor Espinoza-Delgado 3 and Richard L. Piekarz 3,* 1 TRI, Inc., 6500 Rock Spring Dr, Bethesda, MD 20817, USA; E-Mail: VSubramanian@ (S.S.) 2 Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; E-Mail: BatesS@ (S.E.B.) 3 Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, USA; E-Mail: wrigh